As of Jul 26
| +0.18 / +0.42%|
The 15 analysts offering 12-month price forecasts for Metlife have a median target of 51.00, with a high estimate of 62.00 and a low estimate of 42.00. The median estimate represents a +17.81% increase from the last price of 43.29.
The current consensus among 18 polled investment analysts is to Buy stock in Metlife. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.